Artículos del autor

solaci

Antiplatelet

Dual antiaggregation time and death by bleeding

Despite the fact that some randomized studies and meta-analyzis have suggested prolonged dual antiaggregation could be associated...
solaci -
Coronary disease

Primary angioplasty and multivessel lesions: how should we proceed?

Courtesy of Dr Carlos Fava. The association of primary angioplasty with multivessel lesions is not infrequent and has...
solaci -
Institutional News

2nd Edition Multi-Level CTO course 2017

The 2nd Edition of the international Multi-level CTO Course which will be held in Nice (France) from...
solaci -
Structural heart disease

TAVR in Intermediate-Risk Patients: Is It as Effective as Surgical Aortic Valve Replacement?

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has proven to be beneficial for extreme- and high-risk...
solaci -
Coronary disease

Is Impella an option in high-risk angioplasty?

Courtesy of Dr. Carlos Fava. Provitional ventricular assist devices are increasingly used in high-risk angioplasties, particularly those involving unprotected...
solaci -
Other

Is it safe to perform percutaneous treatment in acute pulmonary thrombosis?

Courtesy of Dr. Carlos Fava Massive and submassive pulmonary embolism (PE) has traditionally been treated with anticoagulation and...
solaci -
Bolivia Sessions 2017

And the winners of Bolivia Sessions 2017 are…

Dr. Gastón Heredia (Argentina), from the Universidad Abierta Interamericana (UAI) Hospital, was awarded the prize for “Best Case”...
solaci -
Chronic Ischemic cardiopathy

Bicuspid Aortic Valve Stenosis Still Challenging for TAVR

Courtesy of Dr. Carlos Fava One of the present challenges of TAVR is bicuspid aortic valve stenosis (AS),...
solaci -